Claritev Price to Book Ratio 2019-2024 | CTEV

Historical price to book ratio values for Claritev (CTEV) over the last 10 years. The current price to book ratio for Claritev as of May 16, 2025 is 30.32.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Claritev Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-05-16 27.38 5.28
2024-12-31 14.78 $5.19 2.85
2024-09-30 7.64 $12.84 0.60
2024-06-30 15.52 $37.38 0.42
2024-03-31 32.44 $72.67 0.45
2023-12-31 57.60 $105.45 0.55
2023-09-30 67.20 $107.75 0.62
2023-06-30 84.40 $108.92 0.77
2023-03-31 42.40 $112.67 0.38
2022-12-31 46.00 $112.05 0.41
2022-09-30 114.40 $152.52 0.75
2022-06-30 219.60 $150.77 1.46
2022-03-31 187.20 $149.72 1.25
2021-12-31 177.20 $146.92 1.21
2021-09-30 225.20 $145.88 1.54
2021-06-30 380.80 $142.47 2.67
2021-03-31 222.00 $145.11 1.53
2020-12-31 319.60 $156.19 2.05
2020-09-30 410.00 $1,302.86 0.31
2020-06-30 431.60 $1,348.97 0.32
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.450B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.307B 54.29
Hims & Hers Health (HIMS) United States $13.112B 136.23
Tempus AI (TEM) United States $10.781B 0.00
IRhythm Technologies (IRTC) United States $4.503B 0.00
Inspire Medical Systems (INSP) United States $4.415B 68.98
Privia Health (PRVA) United States $3.036B 207.50
Enovis (ENOV) United States $2.041B 11.38
Clover Health Investments (CLOV) United States $1.735B 0.00
Schrodinger (SDGR) United States $1.706B 0.00
Phreesia (PHR) United States $1.529B 0.00
Omnicell (OMCL) United States $1.315B 23.21
Azenta (AZTA) United States $1.223B 56.83
10x Genomics (TXG) United States $1.125B 0.00
Fulgent Genetics (FLGT) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Talkspace (TALK) United States $0.500B 149.50
Veradigm (MDRX) United States $0.482B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.368B 816.67
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.212B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.207B 0.00
EUDA Health Holdings (EUDA) Singapore $0.147B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.039B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00